HRP20110699T1 - Stabilne tekuće formulacije interferona - Google Patents

Stabilne tekuće formulacije interferona Download PDF

Info

Publication number
HRP20110699T1
HRP20110699T1 HR20110699T HRP20110699T HRP20110699T1 HR P20110699 T1 HRP20110699 T1 HR P20110699T1 HR 20110699 T HR20110699 T HR 20110699T HR P20110699 T HRP20110699 T HR P20110699T HR P20110699 T1 HRP20110699 T1 HR P20110699T1
Authority
HR
Croatia
Prior art keywords
preparation according
present
beta
concentration
container
Prior art date
Application number
HR20110699T
Other languages
English (en)
Croatian (hr)
Inventor
Dorly Del Curto Marina
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of HRP20110699T1 publication Critical patent/HRP20110699T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HR20110699T 2003-12-11 2011-09-30 Stabilne tekuće formulacije interferona HRP20110699T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03104646 2003-12-11
EP04103349 2004-07-13
PCT/EP2004/053407 WO2005058346A1 (en) 2003-12-11 2004-12-10 Stabilized interferon liquid formulations

Publications (1)

Publication Number Publication Date
HRP20110699T1 true HRP20110699T1 (hr) 2011-10-31

Family

ID=34702349

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110699T HRP20110699T1 (hr) 2003-12-11 2011-09-30 Stabilne tekuće formulacije interferona

Country Status (18)

Country Link
US (1) US7846427B2 (de)
EP (1) EP1691825B1 (de)
JP (1) JP4658961B2 (de)
AT (1) ATE526032T1 (de)
AU (1) AU2004298781B2 (de)
BR (1) BRPI0416980A (de)
CA (1) CA2547822A1 (de)
CY (1) CY1112193T1 (de)
DK (1) DK1691825T3 (de)
ES (1) ES2374530T3 (de)
HR (1) HRP20110699T1 (de)
IL (1) IL176021A0 (de)
NO (1) NO20063108L (de)
PL (1) PL1691825T3 (de)
PT (1) PT1691825E (de)
RS (1) RS52218B (de)
SI (1) SI1691825T1 (de)
WO (1) WO2005058346A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI272948B (en) * 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
JP2007538048A (ja) * 2004-05-17 2007-12-27 アレス トレーディング ソシエテ アノニム ヒドロゲル・インターフェロン製剤
CN103965347B (zh) 2007-05-02 2017-07-18 Ambrx公司 经修饰干扰素β多肽和其用途
EP2170268A2 (de) 2007-06-25 2010-04-07 Amgen, Inc. Zusammensetzungen von spezifischen bindungsmitteln für den hepatozyten-wachstumsfaktor
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
BRPI0821029A2 (pt) * 2007-12-20 2015-06-16 Merck Serono Sa Fomulações de peg-interferon-beta
US20100203014A1 (en) * 2009-02-04 2010-08-12 Aegis Therapeutics Llc Zwitterionic buffered acidic peptide and protein formulations
EA201590790A1 (ru) 2012-10-26 2015-08-31 Люпин Лимитед СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
GB201604124D0 (en) * 2016-03-10 2016-04-27 Ucb Biopharma Sprl Pharmaceutical formulation
BR112020005703A2 (pt) 2017-09-27 2020-10-20 Novartis Ag formulação parentérica compreendendo siponimod
CN111494611A (zh) * 2020-06-08 2020-08-07 长春生物制品研究所有限责任公司 一种卡式瓶多剂量笔式注射组合包装的干扰素注射液
CN113797317B (zh) * 2021-10-26 2024-01-09 科兴生物制药股份有限公司 一种组合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997856A (en) 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5814485A (en) * 1995-06-06 1998-09-29 Chiron Corporation Production of interferon-β (IFN-β) in E. coli
ZA9610374B (en) * 1995-12-11 1997-06-23 Elan Med Tech Cartridge-based drug delivery device
JP2001526033A (ja) * 1997-12-08 2001-12-18 ジェネンテク・インコーポレイテッド ヒトインターフェロン−イプシロンというi型インターフェロン
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
RU2004102500A (ru) * 2001-06-29 2005-04-10 Максиген Апс (Dk) Композиции интерферонов
TWI272948B (en) 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
JP2007538048A (ja) 2004-05-17 2007-12-27 アレス トレーディング ソシエテ アノニム ヒドロゲル・インターフェロン製剤
JP4988562B2 (ja) 2004-06-01 2012-08-01 アレス トレーディング ソシエテ アノニム 安定化したインターフェロン液体製剤

Also Published As

Publication number Publication date
NO20063108L (no) 2006-07-04
EP1691825A1 (de) 2006-08-23
ATE526032T1 (de) 2011-10-15
US7846427B2 (en) 2010-12-07
PL1691825T3 (pl) 2012-02-29
CA2547822A1 (en) 2005-06-30
SI1691825T1 (sl) 2011-12-30
JP2007513925A (ja) 2007-05-31
AU2004298781B2 (en) 2010-04-01
DK1691825T3 (da) 2011-12-05
ES2374530T3 (es) 2012-02-17
WO2005058346A1 (en) 2005-06-30
CY1112193T1 (el) 2015-12-09
JP4658961B2 (ja) 2011-03-23
PT1691825E (pt) 2011-10-12
RS52218B (en) 2012-10-31
AU2004298781A1 (en) 2005-06-30
IL176021A0 (en) 2006-10-05
BRPI0416980A (pt) 2007-02-21
EP1691825B1 (de) 2011-09-28
US20070104682A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
HRP20110699T1 (hr) Stabilne tekuće formulacije interferona
ES2198830T3 (es) Uso de agentes quelatantes de metal para estabilizar preparaciones que contienen interferon.
ES2224290T5 (es) Formulaciones l�?quidas estables de interferón.
ES2405994T3 (es) Soluciones estabilizadas de teriparatide
ES2089011T3 (es) Excipiente lipidico de administracion nasal y aplicacion topica.
KR970005305A (ko) 경비 투여용 제제(經鼻投與用製濟)
KR20050099637A (ko) 장기 안정화 제제
JP2011225599A (ja) Hsaを含まない安定なインターフェロン液体製剤
DK1044015T3 (da) Formuleringer med amylinagonistpeptider og insulin
HRP20120483T1 (hr) Formulacije peg interferona beta
KR960030948A (ko) 비강투여용 비무기 식염용액
KR100560697B1 (ko) 알부민을 함유하지 않는 에리스로포이에틴 제제
JP6445169B2 (ja) α型インターフェロンを含有する安定したベンジルアルコールフリーの水溶液製剤
GB2417202A (en) Pharmaceutical preparation comprising calcitonin
MXPA97002578A (en) Alfa-interferonestable acu solution formulations